Cargando…
Salvage locoregional therapies for recurrent hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. Despite the advent of screening efforts and algorithms to stratify patients into appropriate treatment strategies, recurrence rates remain high. In contrast to first-line treatment for HCC, which relies...
Autores principales: | Criss, Cody R, Makary, Mina S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850930/ https://www.ncbi.nlm.nih.gov/pubmed/36688022 http://dx.doi.org/10.3748/wjg.v29.i3.413 |
Ejemplares similares
-
Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors
por: Criss, Cody R., et al.
Publicado: (2023) -
Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Zane, Kylie E., et al.
Publicado: (2021) -
Hepatocellular carcinoma: State of the art diagnostic imaging
por: Criss, Cody, et al.
Publicado: (2023) -
Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
por: Makary, Mina S, et al.
Publicado: (2021) -
Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
por: Makary, Mina S., et al.
Publicado: (2020)